Research Results
Beta Version
Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.
Search by keyword
Select
Select
- All Risk Factors
- Air Pollution
- Alcohol
- Antimicrobials
- Artificial sweeteners
- Bisphenols
- Body Weight
- Breast Density
- Chemical Mixtures
- Chemicals in products
- Cleaning Products
- Diet
- Exercise
- Family History
- Furniture & Electronics
- Genetics
- Gut Health
- Hair Dye
- Hormones
- Inflammation
- Job
- Light at night
- Metals
- Neighborhood
- Night Shift Work
- Noise
- Non-stick Pans & Waterproof Gear
- Oral Contraceptives
- PAHs
- Parabens
- PCBs
- Personal Care Products
- Pesticides
- PFAS
- Pharmaceuticals
- Place-based
- Plastic
- Pregnancy & Breastfeeding
- Processed Food
- Puberty Age
- Race/Ethnicity
- Radiation
- Red meat
- Scented Products & Soft Plastic
- Sleeping Patterns
- Soda
- Stress
- Sugar
- Sunscreen
- Tobacco
- Vitamin D
Select
Select
Select
Select
Select the Chemical Agents
- All Chemical Agents
- 1,1,2,2-TCA
- 1,3-Butadiene
- Acrolein
- Aldrin
- Alkylphenols
- Antimicrobials
- Antimicrobials: QACs, Triclosan, Triclocarban
- Aromatic Amines
- Arsenic
- Artificial Sweeteners
- Atrazine
- Benzene
- Bisphenols
- Cadmium
- Chlordane
- Chlorpyrifos
- DDT
- Dibutyl Phthalate
- Dichlorvos
- Dieldrin
- Dioxins
- ell/
- Ethanol (alcohol)
- Ethyl Benzene
- Ethylene Oxide
- Flame Retardants
- Food
- Formaldehyde
- Glyphosate
- Heptachlor
- Hormones
- Insulin
- Lead
- Light at Night
- Mercury
- Metals
- Methoxyclor
- Naphthalene
- Night Shift Work
- Nitrogen Dioxide
- Noise
- Oral Contraceptives
- Organochlorine Pesticides
- Organophosphate Pesticides
- Ozone
- PAHs
- Parabens
- Particulate Matter
- PCBs
- Pesticides
- PFAS
- Phenols
- Phthalates
- Processed Food
- PVC
- Radiation: Ionizing
- Radiation: Non-Ionizing
- Soda
- Stress
- Sugar
- Tobacco
- Toluene
- Trichloroethylene
- Triclosan
- Ultraviolet Radiation
- UV Filters
- Vinyl Chloride
Select the Study Tags
Sort By
- Relevance
- Title (A to Z)
- Title (Z to A)
- Publication Year (Ascending)
- Publication Year (Descending)
- Authors (A to Z)
- Authors (Z to A)
2022
Cancers
A meta-analysis of 19 case-control studies found that oral contraceptive (OC) use had markedly different effects on breast cancer risk depending on tumor receptor status: OC use was associated with a 37% increased risk of triple-negative breast cancer and a 20% increased risk of ER-negative breast cancer, while showing an 8% reduced risk of ER-positive breast cancer and a non-significant 5% reduced risk of HER2-positive breast cancer. These contrasting associations suggest that oral contraceptives may influence breast cancer development through different biological mechanisms depending on tumor subtype, with particularly concerning implications for triple-negative breast cancer—the most aggressive subtype with limited treatment options. The findings highlight the importance of considering breast cancer heterogeneity when evaluating hormonal contraceptive risks and suggest that women at high risk for triple-negative or ER-negative breast cancer may need alternative contraceptive counseling.
2022
Sleep Breath
A comprehensive meta-analysis of 31 prospective cohort studies including 9.3 million participants found that night-shift work was associated with a modest but statistically significant 2.9% increased breast cancer risk overall, with risk escalating to 8.6% for women working night shifts for more than 10 years and 5.3% for rotating night-shift work specifically. Night-shift workers also showed a 3.1% increased risk of cardiovascular mortality compared to day workers, highlighting broader health impacts beyond cancer. These findings provide strong epidemiological evidence that chronic circadian disruption from night-shift work increases breast cancer risk in a dose-dependent manner, with implications for the millions of women worldwide working non-standard hours in healthcare, manufacturing, transportation, and service industries—suggesting the need for policy interventions to limit long-term night-shift exposure and provide enhanced health monitoring for affected workers.
2022
Biomed Pharmacother
A review of endocrine-disrupting chemicals (EDCs)—ubiquitous substances found in cosmetics, plastic food packaging, and medicines that enter the body through skin, digestive, or respiratory routes—examined their toxic effects even at microgram doses on the female reproductive system and genetic mechanisms. EDCs disrupt endocrine functions by binding to steroid hormone receptors, interfering with hormone synthesis and secretion, and modulating epigenetic processes that can lead to gene expression disturbances, contributing to neoplastic diseases, neurological disorders, circulatory problems, and reproductive dysfunction. Prenatal exposure can affect offspring development, with particular impacts on ovarian function leading to reduced fertility through disturbances in steroid receptor function, steroidogenesis, and gametogenesis. The review emphasizes that despite widespread exposure to these chemicals in everyday products, continued research is needed to fully understand their effects on the female reproductive system and potential transgenerational impacts mediated through epigenetic mechanisms.
2022
J Expo Sci Environ Epidemiol
A comprehensive analysis of 6,793 chemicals in commercial use identified 50 high-priority understudied chemicals that frequently co-occur with known breast cancer-associated chemicals in everyday exposure sources like food, consumer products, and personal care items. Using chemical databases and structural similarity analyses, researchers found these understudied chemicals share physicochemical properties with established mammary carcinogens and potential endocrine disruptors, yet have not been adequately evaluated for breast cancer risk. The findings highlight that real-world chemical exposures occur as mixtures rather than isolated compounds, and that focusing solely on individual well-known chemicals may miss important combination effects—underscoring the urgent need for mixtures-based research in clinical, epidemiological, and toxicological studies to better understand and prevent environmentally-driven breast cancer.
2022
Molecules
A review of endocrine-disrupting compounds (EDCs) in drinking water examines this emerging class of environmental contaminants—ranging from naturally occurring to synthetic compounds—that exist as complex mixtures at trace levels but can cause adverse health effects even at low concentrations. The review covers the perceived and actual health risks of EDC exposure through water ingestion (a major human exposure route), regulatory efforts to limit contamination, and analytical methods including advanced sample preparation, instrumentation, and bioassays for multiclass EDC identification and quantitation. Given that human exposure to EDCs via drinking water poses significant health concerns even at trace concentrations, the ability to detect and evaluate EDC contamination with high sensitivity and accuracy is critically important for protecting public health and informing regulatory policy.
2022
Endocrinology
A review examining PFAS (found in nonstick cookware, food packaging, and stain-resistant fabrics) and parabens (used in personal care products) found that exposure to these endocrine-disrupting chemicals is linked to breast cancer development, with marginalized and socially disadvantaged communities facing disproportionately higher exposures due to structural racism and inequitable environmental conditions. These disparities in chemical exposure may contribute to poorer breast cancer outcomes in these populations, yet breast cancer research continues to underrepresent these communities, limiting our ability to address treatment disparities and improve survival rates. The authors emphasize the urgent need to both reduce EDC exposures in vulnerable communities and increase research inclusion of diverse populations to understand how environmental injustices intersect with breast cancer risk and develop interventions that address these health inequities.
2022
Biomedicines
This study investigates the effects of di-(2-ethylhexyl) phthalate (DEHP), a common plasticizer, on female rats. It found that exposure to DEHP, even at realistic environmental doses, led to significant disruptions in the rats’ reproductive and thyroid systems. More specifically it found that even low exposure to DEHP over a period of 21 days resulted in a significant decrease in the levels of estrogen and progesterone, which correlated with damage to ovarian follicles. Additionally, the thyroid showed signs of damage, including alterations in hormone regulation. The data in this study suggests that DEHP can potentially lead reproductive issues and impaired ovarian and thyroid gland function.
2021
Endocrinology
A comprehensive review of bisphenol A (BPA) research spanning over 20 years—from the landmark 1997 study showing reproductive effects in male mouse offspring at 2 µg/kg/day through the CLARITY-BPA study designed to bridge regulatory and scientific disagreements—found that thousands of animal studies and over 100 epidemiological studies report adverse effects at low doses, with CLARITY-BPA showing effects at 2.5 µg/kg/day, leading independent experts to recommend dropping the lowest observed adverse effect level 20,000-fold from 50,000 to 2.5 µg/kg/day. Despite this overwhelming evidence, the FDA continues to assert BPA is safe by rejecting low-dose data as “not biologically plausible” based on four incorrect assumptions criticized by the Endocrine Society as violating basic principles of endocrinology: that dose responses must be monotonic, thresholds exist below which there are no effects, both sexes must respond similarly, and only traditional toxicological guideline studies are valid. The review highlights a fundamental divide between regulatory approaches and endocrine science, demonstrating that traditional toxicology methods are insufficient for evaluating endocrine-disrupting chemicals like BPA, which can cause non-monotonic dose responses, sex-specific effects, and low-dose effects that challenge conventional assumptions about chemical safety, yet regulatory agencies continue to ignore modern endocrinology principles in favor of outdated toxicological paradigms.
2021
Cancers
A meta-analysis of 42 case-control studies published 2009-2020 including 110,580 women (30,778 breast cancer cases, 79,802 controls) from PubMed, Embase, and Cochrane Library databases examined the association between oral contraceptive (OC) use and breast cancer risk. OC use was associated with a significantly increased breast cancer risk (OR=1.15; 95% CI: 1.01-1.31; p=0.0358), with additional significant risk factors including early menarche, nulliparity, non-breastfeeding, older age at first birth, postmenopause, obesity, smoking, and family history of breast cancer. Despite this meta-analysis and extensive previous studies supporting the conclusion that oral contraceptive pills modestly increase breast cancer risk by approximately 15%, the relatively small effect size, heterogeneity across studies, and authors’ call for further confirmation indicate that the relationship between contemporary OC formulations and breast cancer requires continued investigation, particularly regarding dose-response relationships, specific formulation types, and timing of exposure relative to reproductive events.
2021
BMC Women's Health
A meta-analysis of 26 studies including over 1.3 million participants found that short-term night-shift work (<10 years) was associated with a 13% increased breast cancer risk, but surprisingly, long-term night-shift work (≥10 years) showed no statistically significant increased risk (8% increase, not significant). Flight attendants with long overnight flights showed elevated breast cancer risk, though unmeasured confounders may have influenced these results, and the increased risk in short-term workers was most robust in case-control studies that adjusted for reproductive factors and family history. The paradoxical finding that short-term but not long-term night-shift work showed significant associations contradicts the expected dose-response relationship and may reflect healthy worker bias (where women susceptible to night-shift effects leave such work before reaching 10 years), methodological limitations in measuring long-term exposures, or unmeasured confounding factors that accumulate differently over time.
2021
Int J Health Geogr
A systematic review and dose-response meta-analysis of 17 studies found that exposure to light at night (LAN)—both outdoor and indoor—was associated with an 11% increased breast cancer risk overall, with slightly stronger associations in premenopausal women (16% increased risk) and ER-positive breast cancers (9% increased risk). The dose-response analysis of outdoor LAN showed a linear relationship up to 40 nW/cm²/sr, after which the curve flattened, particularly among premenopausal women, suggesting a threshold effect. These findings provide the first comprehensive dose-response assessment of the LAN-breast cancer relationship and support growing concerns about light pollution as an environmental breast cancer risk factor, with implications for urban planning, building design, and personal light exposure habits—particularly for younger women who appear most vulnerable to the carcinogenic effects of circadian disruption from artificial light exposure at night.
2021
Oncol Rep
A review of organophosphorus pesticides (OPs)—among the most commonly used insecticides—and their association with hormone-mediated cancer found that OPs combined with estrogen induce transformation events in human breast epithelial cells, with in vitro studies showing these substances cause genomic instability through inactivation of tumor-suppressor genes and activation of oncogenes. Studies using immortalized non-tumorigenic human breast epithelial cell lines (MCF-10F) demonstrated that OPs like malathion and parathion, particularly in the presence of estrogen, affect cell cycle regulation, epidermal growth factor signaling pathways, drug metabolism, and genomic stability, leading to cellular transformation and signs of carcinogenesis. The findings suggest hormone-mediated carcinogenic effects of these widely used insecticides on breast cancer risk in women, with experimental models revealing the multistep process by which normal breast cells transform into malignant ones through combined exposure to environmental pesticides and estrogen, providing mechanistic insights into how occupational and environmental OP exposure may contribute to breast cancer development.
2021
Breast
A systematic review of 22 studies found that breast skin harbors distinct bacterial communities, with imbalances in these bacteria—particularly certain Staphylococcus species—linked to breast cancer, metastases, inflammation, and implant complications. The research suggests bacteria can migrate from skin into underlying breast tissue through milk ducts, damaged skin barriers, or nipple fluid, potentially contributing to disease development. These findings indicate that breast skin bacteria may be a modifiable risk factor for breast diseases, opening possibilities for using probiotics, antimicrobials, or microbiome-based diagnostics as new tools for prevention, diagnosis, and treatment of breast conditions.
2021
Aging
A meta-analysis of 14 studies including 312,885 women found that those consuming the most pro-inflammatory diets had a 37% increased breast cancer risk compared to women with the most anti-inflammatory diets. The association was significant in both premenopausal women (87% increased risk) and postmenopausal women (23% increased risk), with notably stronger effects observed in younger women. These findings suggest that dietary patterns promoting chronic inflammation are an independent risk factor for breast cancer across all ages, and that dietary interventions focused on anti-inflammatory foods—such as fruits, vegetables, whole grains, and omega-3 fatty acids—could be an important prevention strategy, particularly for premenopausal women who showed the strongest association.
2021
Adv Pharmacol
A comprehensive review examining endocrine-disrupting chemicals (EDCs) in breast tissue concludes that hundreds of these environmental chemicals are entering human breast tissue and contributing to the global rise in breast cancer incidence through multiple biological mechanisms. Laboratory studies demonstrate that EDCs can activate all the established “hallmarks of cancer” in human breast cancer cells—even at concentrations measured in actual human breast tissue—with effects amplified when chemicals are present as mixtures rather than individually. The authors argue that EDCs must now be formally recognized as a breast cancer risk factor to enable prevention strategies that include reducing environmental chemical exposures, particularly given that the varied mixtures of EDCs found in individual breast tissues act through overlapping mechanisms to promote cancer development.
2021
Environ Res
Biodegradable polymers are emerging as a promising solution for removing endocrine-disrupting chemicals (EDCs) from wastewater. EDC’s, found in pharmaceuticals, pesticides, and personal care products pose serious health risks, impacting the endocrine system and disrupting reproductive health. Traditional water treatments often fail to fully remove EDCs. Biodegradable polymers, with strong adsorptive properties, offer a sustainable and effective method, helping to minimize EDC exposure and protect human and environmental health.
2020
Environ Res
A systematic review of 100 publications across 56 epidemiologic studies found that research enriched with women at higher baseline breast cancer risk—through family history, early-onset disease, or genetic susceptibility—consistently showed stronger and more frequent associations between environmental chemical exposures and breast cancer compared to average-risk populations. Specifically, 80% of studies enriched with family history or early-onset cases showed significant associations with exposures including PAHs, air pollution, DDT, PCBs, PFAS, metals, personal care products, and occupational chemicals, while 74% of studies examining genetic susceptibility found significant gene-environment interactions for various pollutants in women with variants affecting carcinogen metabolism, DNA repair, and oxidative stress. These findings suggest that the inconsistent evidence for environmental chemicals and breast cancer in the literature may partly stem from studying predominantly average-risk populations who may be less susceptible to environmental carcinogens, highlighting the critical need for future research to focus on high-risk populations and measure exposures during key windows of susceptibility (puberty, pregnancy, menopause) to more accurately capture the role of environmental chemicals in breast cancer development.
2020
Medicina
A systematic review of 12 studies examining nurses and shift work found that most studies showed an association between breast cancer and consecutive rotating night shifts prolonged over time, with risk increasing particularly during early adulthood and after 5 or more years of working 6 or more consecutive night shifts. The review identified disruption of circadian rhythm and alterations in peripheral clock genes and reproductive hormones as key mechanisms linking night shift work to breast cancer development, with potential roles for melatonin suppression and epigenetic changes including telomere alterations. These findings are particularly concerning given that nursing is a predominantly female profession requiring 24-hour staffing, suggesting the need for workplace policies that limit consecutive night shifts and total years of night work exposure, along with further research to establish definitive causal mechanisms and identify protective strategies for the millions of women working night shifts globally.
2020
Environ Int
A systematic review and dose-response meta-analysis of 10 cohort studies found no clear association between cadmium exposure and breast cancer risk, whether assessed through dietary intake or urinary excretion levels, with all analyses showing non-significant results. Analysis restricted to postmenopausal women also showed no associations, and while data were insufficient to examine potential associations in specific subgroups defined by age, smoking status, or hormone receptor status, the overall evidence does not support cadmium as a breast cancer risk factor. The authors note that available data were too limited to rule out possible associations in selected vulnerable subgroups, highlighting the need for future studies with better exposure assessment and larger sample sizes to detect subgroup-specific effects if they exist.
2020
Env Health Persp
A systematic review and meta-analysis of 14 studies found that spending one or more hours per day in the sun during summer months was associated with a 16% reduced breast cancer risk compared to less than one hour daily, with similar protective effects observed for both 1-2 hours and more than 2 hours of sun exposure. Sun exposure during adolescence appeared particularly protective (17% risk reduction), while exposure after age 45 showed no significant benefit, and interestingly, ambient UV radiation levels alone were not associated with breast cancer risk. These findings suggest that active sun exposure—likely through Vitamin D production—may offer modest breast cancer protection when obtained regularly during youth and early adulthood, though the results should be balanced against known skin cancer risks from excessive UV exposure.
2020
Alcohol Alcohol
A meta-analysis of 22 cohort studies including 45,350 breast cancer cases found that each 10 grams per day increase in alcohol consumption (approximately one standard drink) was associated with a 10.5% increased breast cancer risk overall, with postmenopausal women showing an 11.1% increased risk per 10 grams daily. Wine showed a similar dose-response relationship (8.9% increased risk per 10g/day), while beer and spirits did not show significant linear associations in the dose-response analysis, and the risk was particularly elevated for estrogen receptor-positive (ER+) breast cancers. The alcohol-attributable percentage of breast cancer cases was highest in Europe compared to North America and Asia, suggesting that current drinking recommendations may need to explicitly address breast cancer risk, particularly for postmenopausal women and wine drinkers.
2020
Pharmacol Res
A comprehensive review of 10 studies including over 3.7 million individuals found that people who had ever used oral antibiotics had an 18% increased risk of breast cancer, with the association varying by antibiotic type—penicillin, tetracycline, and nitrofuran antibiotics showed the strongest links. The relationship appeared complex and possibly non-linear, with data hinting at increased risk with moderate antibiotic use but potential protective effects after 35 or more prescriptions, though this finding requires careful interpretation due to study limitations. It remains unclear whether antibiotics directly cause breast cancer or whether the association reflects other factors like underlying infections, immune function changes, or disruption of the gut microbiome, highlighting the need for further research into the mechanisms behind this relationship.
2020
Medicine
A meta-analysis of 6 studies found that exposure to solar ultraviolet (UV) radiation was associated with a 30% reduced breast cancer risk overall, with a dose-response analysis showing a linear protective relationship in women over 40 (14% risk reduction per unit increase in UV exposure). Notably, not tanning and covering the limbs were associated with increased breast cancer risk, while sunscreen use showed no association with risk, suggesting that actual UV skin exposure—rather than ambient UV levels alone—may be the key protective factor. This is the first dose-response meta-analysis demonstrating that higher UV exposure correlates with lower breast cancer risk in a linear fashion among middle-aged and older women, likely through Vitamin D production, though the findings highlight the complex balance between skin cancer risks from excessive UV exposure versus potential breast cancer protection from adequate sun exposure, and the need for further research on how factors like estrogen receptor status, Occupation, and ethnicity modify this relationship.
2020
Eu J Epidemiol
A large prospective study of over 300,000 Chinese women followed for 10 years found no association between moderate soy intake (averaging 9.4 mg/day of soy isoflavones) and breast cancer risk, even when comparing the highest (19.1 mg/day) to lowest (4.5 mg/day) intake groups. However, a meta-analysis combining this study with other prospective cohorts found that each 10 mg/day increase in soy isoflavone intake was associated with a modest 3% reduction in breast cancer risk. These findings suggest that while moderate soy consumption typical of Chinese diets appears safe and not associated with increased breast cancer risk, higher intakes may provide modest protective benefits, contrasting with earlier concerns about soy and breast cancer and supporting the traditional consumption of soy foods as part of a healthy diet.
2020
Mol Cell Endocrinol
A review of EPA pesticide registration documents found that 28 pesticides cause mammary tumors in animals and five alter mammary gland development, yet the agency’s risk assessments often dismiss these findings or don’t evaluate their implications for breast cancer risk. Many of these pesticides work through hormone-disrupting pathways that could affect breast tissue, including common chemicals like malathion, atrazine, and triclopyr. The authors argue that current testing guidelines don’t adequately assess effects on the mammary gland and call for re-evaluation of several widely-used pesticides based on stronger standards informed by breast cancer biology.
2020
Food Chem Tox
This article discusses the harmful impacts of polycyclic aromatic hydrocarbons (PAHs) found in deep-fried foods. It highlights their endocrine-disrupting, genotoxic, and carcinogenic abilities when oils used for deep frying are heated repeatedly or at high temperatures. PAHs disrupt steroidogenic pathways which can lead to hormonal imbalances of estrogen and testosterone causing lower sperm quality, estrogenic effects, and endocrine related disorders. Furthermore, PAHs are linked to increased cancer risks through genotoxicity which can cause mutations in the cell. Organ sites that can be affected by this cancer risk are the breast, prostate, colorectal, renal, and pancreas.
2019
Int Arch Occup Environ Health
A systematic review and meta-analysis of 30 studies (with meta-analyses conducted on 13 studies) examined the association between occupational ethylene oxide (EO) exposure and risk of lympho-hematopoietic cancers (LHC) and breast cancer. The overall pooled meta-relative risk was 1.48 (95% CI: 1.07-2.05) for LHC and 0.97 (95% CI: 0.80-1.18) for breast cancer, with meta-RRs for LHC among EO production workers at 1.46 and sterilization workers at 1.07, neither reaching statistical significance. Notably, a clear temporal trend emerged showing substantially higher LHC risk estimates in earlier studies from the 1980s (meta-RR = 3.87) that progressively declined in more recent decades, with studies from the 2000s and 2010s showing meta-RRs of 1.05 and 1.19 respectively, neither statistically significant. The authors conclude that the most informative and methodologically rigorous epidemiological studies published in recent decades do not support an association between occupational ethylene oxide exposure and increased risk of either lympho-hematopoietic cancers or breast cancer, suggesting that earlier positive findings may have been influenced by methodological limitations, exposure misclassification, or confounding factors that have been better controlled in more recent research.
2019
Breast Cancer Res Treat
A systematic review and meta-analysis of 11 cohort studies found that a history of stressful life events was associated with an 11% increased risk of breast cancer (pooled risk ratio: 1.11, 95% CI: 1.03-1.19). While the increase is modest, the finding suggests that psychological stress may play a role in breast cancer development and that women who experience significant life stressors could benefit from psychological and counseling services as a potential preventive measure. These results add to growing evidence linking chronic stress exposure to cancer risk and underscore the importance of addressing mental health and stress management as part of comprehensive breast cancer prevention strategies.
2019
Medicine
A meta-analysis of 10 studies including 8,585 breast cancer cases among 686,305 participants examined the relationship between age at first oral contraceptive (OC) use and breast cancer risk through June 2018. The pooled analysis found a 24% increased breast cancer risk associated with earlier age at first OC use (RR = 1.24; 95% CI: 1.10-1.41), with a significant linear dose-response relationship indicating that younger age at first use was associated with higher breast cancer risk. However, subgroup analyses showed inconsistent results with no statistical significance when restricted to studies from Western countries, lower quality studies, smaller sample sizes, shorter follow-up periods, or when stratified by breast cancer subtypes defined by estrogen receptor (ER), progesterone receptor (PR), or HER2 status. The findings suggest that starting oral contraceptive use at a younger age may increase breast cancer risk in a dose-dependent manner, though this association appears to be influenced by study characteristics and may not differ consistently across hormone receptor-defined breast cancer subtypes, highlighting the need for further research to clarify these relationships and inform contraceptive counseling for young women.
2019
Eur J Clinic Nutr
A meta-analysis of 23 prospective studies including 41,516 breast cancer cases and 1,171,048 individuals found that higher folate intake was associated with reduced risk of ER-/PR- breast cancer (RR = 0.82; 95% CI: 0.68-0.97), with each 100 μg/day increment decreasing risk by 6% for ER- and 10% for ER-/PR- subtypes. Additionally, high folate intake showed protective effects in premenopausal women (RR = 0.94) and individuals with moderate-to-high alcohol consumption (RR = 0.82), suggesting folate may be particularly beneficial for hormone receptor-negative breast cancers and specific high-risk populations.
2018
Food Chem Tox
A systematic review of 25 studies examining phthalates (plastic chemicals) and breast cancer found that while laboratory studies show certain phthalates can activate estrogen receptors and promote cancer cell growth, epidemiological studies in humans have produced mixed and inconclusive results. The main source of phthalate exposure is through diet—particularly from food and beverages in plastic packaging—but current human studies have significant limitations in how they measure exposure and account for other risk factors. The review calls for better-designed future studies that use hair samples instead of urine for more accurate long-term exposure assessment, include dietary factors and genetic markers as confounders, and investigate phthalates’ effects beyond just estrogen-driven cancers to include all breast cancer subtypes.
Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-analysis.
2018
Clinic Breast Cancer
A systematic review and meta-analysis of 9 studies including 296,102 participants found that higher dietary inflammatory potential was associated with a 14% increased breast cancer risk overall, though the association varied by study design with case-control studies showing stronger effects (63% increased risk, not statistically significant) than cohort studies (4% increased risk, not significant). The pooled analysis across all study types showed a significant positive association between pro-inflammatory diets and breast cancer, suggesting that dietary modifications to reduce inflammatory potential could meaningfully reduce breast cancer risk. These findings reinforce that chronic low-grade inflammation driven by diet—characterized by high intake of refined carbohydrates, red and processed meats, and trans fats with low consumption of anti-inflammatory foods like fruits, vegetables, whole grains, and omega-3 fatty acids—contributes to breast carcinogenesis, supporting dietary pattern interventions focused on anti-inflammatory foods as an accessible and modifiable prevention strategy for women.
2018
Scand J Work Environ Health
A comprehensive review of seven meta-analyses published 2013-2016 examining night shift work and breast cancer risk (collectively including 30 cohort and case-control studies from 1996-2016) found that pooled effect sizes for ever/never night shift work exposure ranged from 0.99 (95% CI: 0.95-1.03, N=10 cohort studies) to 1.40 (95% CI: 1.13-1.73, N=9 high-quality studies), with most showing statistically significant between-study heterogeneity but no evidence of publication bias, while estimates for duration, frequency, and cumulative exposure were scarce and mostly non-significant. Meta-analyses of cohort studies, Asian populations, and more fully-adjusted studies generally yielded lower pooled estimates than case-control, European/American, or minimally-adjusted studies, and AMSTAR 2 quality assessment revealed only one meta-analysis was strong in critical quality domains. The findings show fairly consistent modest elevations in breast cancer risk for ever/never night shift work exposure but inconclusive results for other shift work metrics, highlighting the need for future evaluations incorporating high-quality meta-analyses with better individual study quality appraisal to clarify the relationship between specific night shift work characteristics (duration, frequency, timing) and breast cancer risk.
2018
Environ Res
A systematic review of 158 studies examining environmental chemicals and breast cancer found the strongest evidence for increased risk from exposures during critical developmental periods (in utero, adolescence, pregnancy) to DDT, dioxins, PFOSA, air pollution, and occupational solvents, with risk estimates ranging from 1.4 to 5 times higher. A landmark 50-year study that captured DDT exposure during windows of breast development showed particularly elevated risks, while research on genetic variations found that women with certain DNA repair gene variants had higher breast cancer risk from PAH (polycyclic aromatic hydrocarbon) exposure. However, most studies failed to assess exposure timing during biologically relevant windows of susceptibility, and many current-use chemicals in consumer products remain inadequately studied, with major challenges including reconstructing decades-old exposures and measuring rapidly metabolized chemicals in complex real-world mixtures.
2018
Cancer Epidemiol Biomark Prev
A systematic review and meta-analysis of 24 studies found suggestive evidence that physical activity may reduce breast cancer risk through increased global DNA methylation, with higher activity levels showing a trend toward higher methylation (19% standardized mean difference) and higher methylation associated with a 30% reduced breast cancer risk, though neither association reached statistical significance overall. Subgroup analyses revealed that the protective pathway became clearer when examining long-term physical activity patterns and prospective cohort studies specifically, where both associations were statistically significant. This is the first systematic review to examine the complete biological pathway linking physical activity to breast cancer prevention through epigenetic mechanisms, suggesting that exercise may alter DNA methylation patterns in ways that protect against cancer development—a finding that could help explain how physical activity exerts its well-established cancer-preventive effects at the molecular level.
2018
BMC Pub Health
A mixed ecological and case-control study in Australia found that obesity occurring between ages 31-40 was independently associated with a 250% increased breast cancer risk in middle-aged women, though no direct association was found between alcohol consumption and breast cancer in the case-control analysis despite ecological correlations. The study revealed that stress was ecologically linked to both alcohol consumption and obesity but not directly to breast cancer incidence, suggesting that stress may influence breast cancer risk indirectly through health behaviors rather than representing a “missing link” as hypothesized. These findings highlight a critical window for breast cancer prevention: obesity in the decade before age 40 appears particularly risky, supporting targeted weight management interventions for women in their 30s, while the complex interrelationships between stress, alcohol, obesity, and breast cancer warrant further investigation using longitudinal designs that can capture temporal sequences and cumulative exposures across women’s reproductive years.
2018
Curr Oncol Rep
Obesity is now recognized as a leading preventable cause of cancer, particularly postmenopausal estrogen receptor-positive breast cancer, and is associated with worse outcomes across all breast cancer subtypes. Multiple interconnected mechanisms link obesity to breast cancer, including elevated estrogen levels, altered hormone-like molecules from fat tissue (leptin and adiponectin), disrupted insulin signaling, changes in gut bacteria, and chronic inflammation throughout the body. Understanding these complex pathways could lead to new prevention and treatment strategies to reduce the growing burden of obesity-related breast cancers worldwide.
2016
Cancer Med
A review examining breast cancer disparities in African American women—who now have similar incidence rates to non-Hispanic White women but significantly higher mortality—found growing evidence linking hair product use to breast cancer risk through exposure to estrogen-like chemicals and endocrine-disrupting chemicals (EDCs). The review identified three converging lines of evidence: environmental estrogen and EDC exposures increase breast cancer risk, these chemicals are present in personal care products including hair products, and certain hair products used disproportionately by African American women may contribute to elevated breast cancer risk in this population. The findings highlight an understudied environmental justice issue and call for additional research using community-collaborative approaches to better understand how culturally specific beauty practices may contribute to health disparities, representing what researchers term the potential “cost of beauty.”
2015
Carcinogenesis
A review examining the intersection of environmental toxicants, immune function, and cancer development argues that common chemicals like bisphenol A, atrazine, and phthalates can disrupt the delicate balance between pro- and anti-inflammatory immune responses, potentially contributing to tumor development through immune system dysfunction. The authors highlight that while the role of immunity in cancer is well-established, research on how environmental chemicals affect immune cells as co-factors in cancer causation remains underdeveloped compared to studies on autoimmunity and allergies. The review calls for increased research using systems biology approaches to better understand how chemical exposures disturb inflammatory pathways and immune molecules involved in tumor-associated inflammation, arguing that chemically induced immune perturbations represent an important but understudied mechanism of environmental carcinogenesis.
2015
Carcinogenesis
This study explores the linkage between environmental chemical exposures and cellular resistance to cell death, a carcinogenic trait. The researchers in this study specifically investigate BPA, chlorothalonil, dibutyl phthalate, and more because of their disruptive effects that may be involved in these carcinogenic pathways. The researchers found that arsenic interferes with cellular signaling pathways and induces oxidative stress, leading to impaired apoptosis; dioxins bind to aryl hydrocarbon receptors (AHRs), which alters gene expression and disrupts normal cell death processes; BPA mimics the estrogen hormone, affecting hormonal balance and promoting cell survival pathways that inhibit cell death. By allowing cells to evade cell death, these environmental chemicals can promote the survival of cells with genetic mutations and therefore increase the risk of cancer development.
2014
Environ Health Perspect
This review of exposure biomarkers for chemicals potentially linked to breast cancer identified methods for 102 chemicals causing mammary tumors in rodents, finding biomarkers for nearly 75% of them, with human exposure biomarkers existing for 62 chemicals (45 measured in non-occupationally exposed populations) and the CDC tracking 23 of them. Among rodent mammary carcinogens with >50% population detection frequency were PAHs (98%), methyleugenol (98%), PFOA (>50%), chlordane (>50%), acrylamide (>50%), and benzene (>50%), indicating near-universal exposure to multiple mammary carcinogens, with several additional chemicals showing >50% detection of urinary metabolites including ethylene oxide, acrylonitrile, fenvalerate, and vinyl chloride (71-75%). The study found consistent carcinogenicity between humans and rodents for many chemicals, though limited data exists for direct effects in humans, and emphasizes the availability of biomonitoring tools and resources to advance breast cancer prevention efforts. The findings underscore that populations are ubiquitously exposed to multiple known mammary carcinogens simultaneously, highlighting the urgent need for biomonitoring programs to assess mixed exposures and inform prevention strategies targeting modifiable environmental risk factors for breast cancer.
2014
Aging Dis
The following review article described how exposure to EDCs during early development can lead to adverse health outcomes later in life through epigenetic mechanisms based on existing studies. The article emphasizes that exposure to EDCs during critical developmental periods such as in utero and early childhood, can have lasting effects on health since, during these periods, the body’s systems are particularly vulnerable to exposures. Additionally, the article finds a link between early-life exposure to EDCs and increased risk of various health issues later on in life, including metabolic disorders and cancers. The suspected mechanism by which these chemicals do this is thought to be mediated by epigenetic changes, which are changes to gene expression without altering the DNA. Therefore, the article emphasizes understanding how exposure during such sensitive periods in development can pose such drastic problems later on in life.
2011
J Steroid Biochem Mol Biol
Bisphenol A (BPA) is a widely produced chemical used in plastics and food container linings, with frequent human exposure due to its leaching into food and beverages. BPA, a known endocrine disruptor, was initially deemed a weak estrogen but has shown potency comparable to estradiol, a form of estrogen, shown to affect multiple hormonal pathways. Studies on rodents reveal adverse effects at levels below and at the current acceptable daily intake, raising concerns about human health impacts about concentration. BPA’s estrogenic effects highlight the importance of investigating BPA’s complex, widespread impacts on health.
2025
Int J Cancer
The “estrobolome”—gut bacteria involved in processing estrogens and related compounds—has been theorized to influence breast cancer risk by affecting hormone levels, but a comprehensive review found limited and inconsistent evidence linking specific bacterial species to breast cancer. Only two bacteria (Escherichia coli and Roseburia inulinivorans) showed both functional relevance and differences between breast cancer patients and healthy controls, suggesting that either measurement methods need improvement or that broader ecological changes in the gut microbiome are more important than specific estrogen-processing bacteria. The review calls for future studies using advanced techniques like metabolomics and transcriptomics alongside microbiome sequencing to better understand whether and how gut bacteria influence breast cancer through hormone pathways, while accounting for lifestyle and clinical factors that may modify these relationships.
2007
Cancer
A comprehensive review found that while laboratory studies have identified numerous environmental chemicals that cause breast tumors in animals or mimic estrogen, human epidemiological evidence is strongest for PAHs (found in air pollution and grilled foods) and PCBs (banned industrial chemicals), particularly in women with certain genetic variations affecting how their bodies process these chemicals and hormones. Evidence linking dioxins and organic solvents to breast cancer is limited but suggestive, while many chemicals identified as mammary carcinogens in animal studies have never been investigated in human populations due to challenges in measuring past exposures and the decades-long delay between exposure and cancer diagnosis. The review argues that given these methodological limitations in human studies, policymakers should rely more heavily on animal and laboratory evidence to develop regulations that reduce chemical exposures, as waiting for definitive human proof may unnecessarily delay prevention strategies that could reduce breast cancer rates.